FLT3-ITD
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE (NCT05193448) | French Innovative Leukemia Organisation | 2021-07-05 |
Track FLT3-ITD automatically
Every clearance here is in the API, with alerts when new ones post.